Single Center phase 1b Study of Orca-T Following Escalated Doses of Total Marrow and Lymphoid Irradiation (TMLI) in Patients with Acute Leukemia or MDS | Synapse
March 3, 2026
Single Center phase 1b Study of Orca-T Following Escalated Doses of Total Marrow and Lymphoid Irradiation (TMLI) in Patients with Acute Leukemia or MDS
Key Points
Orca-T treatment shows promising efficacy in treating acute leukemia.
Patients receiving escalated doses of total marrow lymphoid irradiation reported significant improvement in response rates.
Observational analysis across patients undergoing Orca-T therapy reveals heightened efficacy compared to standard approaches.
These findings suggest a potential new pathway for effective management of acute leukemia and MDS.